Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

On Demand

Pharma & (Bio)Synthetics


Average Rating:
Not yet rated
Categories:
Intellectual Property |  Advertising, Packaging and Labeling |  Copyrights and Trademarks |  Patents & Trade Secrets |  Licensing
Faculty:
Nicole Grimm |  Jonathan Cousin |  Ethan Russo |  Shahnam Sharareh
Duration:
59 Minutes
Format:
Audio and Video
SKU:
INCBA112920PH
License:
Access for 6 month(s) after purchase.


Description

Join us for a discussion on the strategic considerations and requirements for securing patent and patent-like protection for cannabis-related inventions, including Utility Patents, Plant Patents and PVP. The panel will delve into the practical requirements for preparing and prosecuting each form of protection, including a discussion of deposit requirements (availability to 3rd parties and timing of deposits), data quality, scope (written description/enablement), and the dynamics for Plant Patent-Flexibility and data quality requirements

Credits


General

This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)


For current accreditation status, please select your jurisdiction below.



Handouts

Faculty

Nicole Grimm's Profile

Nicole Grimm Related Seminars and Products

IP Attorney

McDonnell Boehnen Hulbert & Berghoff


Jonathan Cousin's Profile

Jonathan Cousin Related Seminars and Products

Associate

Cooley LLP


Jon advises pharmaceutical companies and specializes in integrating regulatory and patent exclusivity strategies in order to maximize the value of his clients’ products. He has worked on several Orange Booklisted products. He works closely with his clients to develop and implement patent strategies, with a particular focus on late-stage clinical trial inventions that provide significant additional patent protection. He also has experience conducting patentability, invalidity, freedom-to-operate/non-infringement analyses, IPOs, and due diligence for acquisitions and sales. Jon has counseled clients in a variety of technologies including pharmaceutical formulations and methods of treatment based on clinical trials, new chemical entities, biotechnologies, companion diagnostics, purification processes, polymers, and food additives. He represents clients of all sizes, including startups, specialty pharma, and publicly traded companies. Jon knew he wanted to work with cutting edge pharmaceutical products, so he pursued in PhD in organic chemistry after earning his JD. Jon's doctoral research focused on the synthesis of multivalent ligands to study biological recognition processes in cancer. While pursuing his PhD, Jon was also in-house patent counsel at Montana State University’s Technology Transfer Office. 


Ethan Russo's Profile

Ethan Russo Related Seminars and Products

Founder/CEO

CReDO Science


Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and author. He is the Founder and CEO of CReDo Science www.credo-science.com

 

Previously, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague, Czech Republic: https://www.icci.science. Medical Director of PHYTECS (2015-2017), a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (http://www.phytecs.com), and from 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy (https://www.gwpharm.com).

 

He graduated from the University of Pennsylvania (Psychology), and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula, Montana for 20 years in a practice with a strong chronic pain component. In 1995, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu, Peru. 

 

He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Chinese Academy of Sciences, Harvard University, and Johns Hopkins University. 

 

He is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs, co-editor of Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS, Women and Cannabis: Medicine, Science and Sociology, Cannabis: From Pariah to Prescription, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters, and over fifty articles in neurology, pain management, cannabis, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms, phytopharmaceutical treatment of migraine and chronic pain, herbal synergy and phytocannabinoid/terpenoid, serotonergic and vanilloid interactions.   

 

He has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.


Shahnam Sharareh's Profile

Shahnam Sharareh Related Seminars and Products

Patent Attorney

Fox Rothschild LLP


Shahnam is a registered patent attorney who advises global pharmaceutical, agricultural, and other life science and technology companies on all aspects of patent portfolio development, analysis and appeals, as well as post-grant proceedings and intellectual property transactional activities. He has prepared and prosecuted more than 1,000 U.S. and international patent applications and, as a former patent examiner, provides customized approaches to his clients in a wide range of technologies, including chemistry, pharmaceuticals, pharmacology, biotechnology, medical diagnostics and cosmetic products.

 

He provides a full range of patent law services to clients, including infringement and validity studies, freedom-to-practice studies and design-around to help clients achieve their strategic and commercial goals. He has also appeared before the Patent Trial and Appeal Board in a number of proceedings on behalf of his clients.

 

As a Regulatory Affairs Certified (RAC) professional, Shahnam utilizes a strong understanding of the regulatory framework of cannabis and hemp-derived CBD products to advise clients on FDA regulatory matters, marketing and advertising strategies for drug and dietary supplement products.


Alternate Options

Genetics & Bioscience
Original Program Date: 11/29/2020 - SKU INCBA112920GE

Reviews